Five hundred forty-two specimens of 150 children enrolled in the AML-Berlin-Frankfurt-Muenster (BFM) 98 study were analyzed by four-color immunophenotyping at up to four predefined time points during ...
Artificial intelligence may be leveraged to improve minimal residual disease measurements for patients. A new review outlines the role of minimal residual disease (MRD) assessments via blood component ...
FREMONT, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the launch of a new 20-Color Acute Myeloid ...
Our lab studies cell signaling and epigenetic pathways in an aggressive form of bone marrow cancer called acute myeloid leukemia (AML). Our primary focus is on a subtype of AML with mutations in FLT3, ...
John Routzahn, University of Delaware class of 2024 Applied Molecular Biology and Biotechnology (AMBB), won an NIH grant to do summer research at the National Cancer Institute in Fort Detrick as part ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback